Profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: RE-COVERY DVT/PE study

In randomized clinical trials (RCTs) of nonvitamin K antagonist oral anticoagulants (NOACs) for acute venous thromboembolism (VTE), similar to 12-13% of patients were elderly and similar to 26% had mild-to-moderate renal impairment. Observational studies are not restricted by the selection and treat...

Full description

Saved in:
Bibliographic Details
Main Authors: Ageno, Walter, Casella, Ivan B., Chee, Kok Han, Schellong, Sebastian, Schulman, Sam, Singer, Daniel E., Desch, Marc, Tang, Wenbo, Voccia, Isabelle, Zint, Kristina, Goldhaber, Samuel Z.
Format: Article
Published: Springer 2021
Subjects:
Online Access:http://eprints.um.edu.my/34413/
Tags: Add Tag
No Tags, Be the first to tag this record!
id my.um.eprints.34413
record_format eprints
spelling my.um.eprints.344132022-09-13T08:01:31Z http://eprints.um.edu.my/34413/ Profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: RE-COVERY DVT/PE study Ageno, Walter Casella, Ivan B. Chee, Kok Han Schellong, Sebastian Schulman, Sam Singer, Daniel E. Desch, Marc Tang, Wenbo Voccia, Isabelle Zint, Kristina Goldhaber, Samuel Z. R Medicine (General) In randomized clinical trials (RCTs) of nonvitamin K antagonist oral anticoagulants (NOACs) for acute venous thromboembolism (VTE), similar to 12-13% of patients were elderly and similar to 26% had mild-to-moderate renal impairment. Observational studies are not restricted by the selection and treatment criteria of RCTs. In this ancillary analysis of the RE-COVERY DVT/PE global observational study, we aimed to describe patient characteristics, comorbidities, and anticoagulant therapy for subgroups of age (< or >= 75 years) and renal impairment (creatinine clearance CrCl; estimated with Cockcroft-Gault formula] < 30 severe], 30 to < 50 moderate], 50 to < 80 mild], >= 80 normal] mL/min). Of 6095 eligible patients, 25.3% were aged >= 75 years; 38.2% (1605/4203 with CrCl values) had mild-to-moderate renal impairment. Comorbidities were more common in older patients (73.9% aged >= 75 vs. 58.1% < 75 years) and in those with mild or moderate versus no renal impairment (75.9%, 80.9%, and 59.3%, respectively). At hospital discharge or 14 days after diagnosis (whichever was later), most patients (53.7% and 55.1%, respectively) in both age groups received NOACs; 20.8% and 23.4%, respectively, received vitamin K antagonists, 19.0% and 21.8% parenteral therapy, 2.3% and 3.8% other anticoagulant treatments. Use of NOACs decreased with worsening renal impairment (none 58.5%, moderate 49.6%, severe 25.7%) and, in younger versus older patients with moderate renal impairment (33.1% vs. 56.1%). In routine practice, there are more elderly and renally impaired patients with VTE than represented in RCTs. Decreasing renal function, but not older age, was associated with less NOAC use. Clinical Trial Registration:. Unique identifier: NCT02596230. Graphic abstract Decreasing renal function, particularly in the subgroup with CrCl < 30 mL/min, but not older age, was associated with less use of nonvitamin K antagonist oral anticoagulants (NOACs). Nevertheless, more than half of the older patients with moderate renal impairment received a NOAC as their oral anticoagulant. Springer 2021-04 Article PeerReviewed Ageno, Walter and Casella, Ivan B. and Chee, Kok Han and Schellong, Sebastian and Schulman, Sam and Singer, Daniel E. and Desch, Marc and Tang, Wenbo and Voccia, Isabelle and Zint, Kristina and Goldhaber, Samuel Z. (2021) Profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: RE-COVERY DVT/PE study. Journal of Thrombosis And Thrombolysis, 51 (3). pp. 561-570. ISSN 0929-5305, DOI https://doi.org/10.1007/s11239-020-02239-9 <https://doi.org/10.1007/s11239-020-02239-9>. 10.1007/s11239-020-02239-9
institution Universiti Malaya
building UM Library
collection Institutional Repository
continent Asia
country Malaysia
content_provider Universiti Malaya
content_source UM Research Repository
url_provider http://eprints.um.edu.my/
topic R Medicine (General)
spellingShingle R Medicine (General)
Ageno, Walter
Casella, Ivan B.
Chee, Kok Han
Schellong, Sebastian
Schulman, Sam
Singer, Daniel E.
Desch, Marc
Tang, Wenbo
Voccia, Isabelle
Zint, Kristina
Goldhaber, Samuel Z.
Profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: RE-COVERY DVT/PE study
description In randomized clinical trials (RCTs) of nonvitamin K antagonist oral anticoagulants (NOACs) for acute venous thromboembolism (VTE), similar to 12-13% of patients were elderly and similar to 26% had mild-to-moderate renal impairment. Observational studies are not restricted by the selection and treatment criteria of RCTs. In this ancillary analysis of the RE-COVERY DVT/PE global observational study, we aimed to describe patient characteristics, comorbidities, and anticoagulant therapy for subgroups of age (< or >= 75 years) and renal impairment (creatinine clearance CrCl; estimated with Cockcroft-Gault formula] < 30 severe], 30 to < 50 moderate], 50 to < 80 mild], >= 80 normal] mL/min). Of 6095 eligible patients, 25.3% were aged >= 75 years; 38.2% (1605/4203 with CrCl values) had mild-to-moderate renal impairment. Comorbidities were more common in older patients (73.9% aged >= 75 vs. 58.1% < 75 years) and in those with mild or moderate versus no renal impairment (75.9%, 80.9%, and 59.3%, respectively). At hospital discharge or 14 days after diagnosis (whichever was later), most patients (53.7% and 55.1%, respectively) in both age groups received NOACs; 20.8% and 23.4%, respectively, received vitamin K antagonists, 19.0% and 21.8% parenteral therapy, 2.3% and 3.8% other anticoagulant treatments. Use of NOACs decreased with worsening renal impairment (none 58.5%, moderate 49.6%, severe 25.7%) and, in younger versus older patients with moderate renal impairment (33.1% vs. 56.1%). In routine practice, there are more elderly and renally impaired patients with VTE than represented in RCTs. Decreasing renal function, but not older age, was associated with less NOAC use. Clinical Trial Registration:. Unique identifier: NCT02596230. Graphic abstract Decreasing renal function, particularly in the subgroup with CrCl < 30 mL/min, but not older age, was associated with less use of nonvitamin K antagonist oral anticoagulants (NOACs). Nevertheless, more than half of the older patients with moderate renal impairment received a NOAC as their oral anticoagulant.
format Article
author Ageno, Walter
Casella, Ivan B.
Chee, Kok Han
Schellong, Sebastian
Schulman, Sam
Singer, Daniel E.
Desch, Marc
Tang, Wenbo
Voccia, Isabelle
Zint, Kristina
Goldhaber, Samuel Z.
author_facet Ageno, Walter
Casella, Ivan B.
Chee, Kok Han
Schellong, Sebastian
Schulman, Sam
Singer, Daniel E.
Desch, Marc
Tang, Wenbo
Voccia, Isabelle
Zint, Kristina
Goldhaber, Samuel Z.
author_sort Ageno, Walter
title Profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: RE-COVERY DVT/PE study
title_short Profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: RE-COVERY DVT/PE study
title_full Profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: RE-COVERY DVT/PE study
title_fullStr Profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: RE-COVERY DVT/PE study
title_full_unstemmed Profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: RE-COVERY DVT/PE study
title_sort profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: re-covery dvt/pe study
publisher Springer
publishDate 2021
url http://eprints.um.edu.my/34413/
_version_ 1744649178554826752
score 13.211869